148 related articles for article (PubMed ID: 33271290)
21. COVID-19 in Immunocompromised Cancer Patients: A Case Series and Review of the Literature.
Patel RH; Vanaparthy R; Greene JN
Cancer Control; 2021; 28():10732748211044361. PubMed ID: 34579537
[TBL] [Abstract][Full Text] [Related]
22. Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice.
Liu X; Zaid A; Freitas JR; McMillan NA; Mahalingam S; Taylor A
mBio; 2021 Apr; 12(2):. PubMed ID: 33879586
[TBL] [Abstract][Full Text] [Related]
23. COVID-19 Mortality Risk in Down Syndrome: Results From a Cohort Study of 8 Million Adults.
Clift AK; Coupland CAC; Keogh RH; Hemingway H; Hippisley-Cox J
Ann Intern Med; 2021 Apr; 174(4):572-576. PubMed ID: 33085509
[No Abstract] [Full Text] [Related]
24. Immunology of Transplant Patients with SARS-CoV-2 Infection: Transmission, Immune Response, and Therapeutic Strategy.
Wang M; Zhao Y; Wei L; Chen D; Yang B; Chen Z
Crit Rev Immunol; 2020; 40(6):475-484. PubMed ID: 33900692
[TBL] [Abstract][Full Text] [Related]
25. Investigation of CD26, a potential SARS-CoV-2 receptor, as a biomarker of age and pathology.
Raha AA; Chakraborty S; Henderson J; Mukaetova-Ladinska E; Zaman S; Trowsdale J; Raha-Chowdhury R
Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33205807
[TBL] [Abstract][Full Text] [Related]
26. Clinical Characteristics of Patients with Severe Pneumonia Caused by the SARS-CoV-2 in Wuhan, China.
Wang Y; Zhou Y; Yang Z; Xia D; Hu Y; Geng S
Respiration; 2020; 99(8):649-657. PubMed ID: 32841948
[TBL] [Abstract][Full Text] [Related]
27. False-positive and false-negative COVID-19 cases: respiratory prevention and management strategies, vaccination, and further perspectives.
Mouliou DS; Gourgoulianis KI
Expert Rev Respir Med; 2021 Aug; 15(8):993-1002. PubMed ID: 33896332
[No Abstract] [Full Text] [Related]
28. Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths.
Lai CC; Liu YH; Wang CY; Wang YH; Hsueh SC; Yen MY; Ko WC; Hsueh PR
J Microbiol Immunol Infect; 2020 Jun; 53(3):404-412. PubMed ID: 32173241
[TBL] [Abstract][Full Text] [Related]
29. [Detection and evaluation of SARS-CoV-2 nucleic acid contamination in corona virus disease 19 ward surroundings and the surface of medical staff's protective equipment].
Yuan XN; Meng QY; Shen N; Li YX; Liang C; Cui M; Ge QG; Li XG; Tan K; Chen Q; Wang J; Zeng XY
Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Oct; 52(5):803-808. PubMed ID: 33047711
[TBL] [Abstract][Full Text] [Related]
30. Non-alcoholic Fatty Liver Disease and COVID-19 Susceptibility and Outcomes: a Korean Nationwide Cohort.
Yoo HW; Jin HY; Yon DK; Effenberger M; Shin YH; Kim SY; Yang JM; Kim MS; Koyanagi A; Jacob L; Smith L; Yoo IK; Shin JI; Lee SW
J Korean Med Sci; 2021 Oct; 36(41):e291. PubMed ID: 34697932
[TBL] [Abstract][Full Text] [Related]
31. Co-infection of SARS-CoV-2 with other respiratory viruses and performance of lower respiratory tract samples for the diagnosis of COVID-19.
Burrel S; Hausfater P; Dres M; Pourcher V; Luyt CE; Teyssou E; Soulié C; Calvez V; Marcelin AG; Boutolleau D
Int J Infect Dis; 2021 Jan; 102():10-13. PubMed ID: 33115679
[TBL] [Abstract][Full Text] [Related]
32. Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review.
Kulanthaivel S; Kaliberdenko VB; Balasundaram K; Shterenshis MV; Scarpellini E; Abenavoli L
Rev Recent Clin Trials; 2021; 16(2):138-145. PubMed ID: 32940187
[TBL] [Abstract][Full Text] [Related]
33. Update on SARS-CoV-2 infection in children.
Martins MM; Prata-Barbosa A; da Cunha AJLA
Paediatr Int Child Health; 2021 Feb; 41(1):56-64. PubMed ID: 33616026
[TBL] [Abstract][Full Text] [Related]
34. [SARS-CoV-2 and Microbiological Diagnostic Dynamics in COVID-19 Pandemic].
Erensoy S
Mikrobiyol Bul; 2020 Jul; 54(3):497-509. PubMed ID: 32755524
[TBL] [Abstract][Full Text] [Related]
35. Clinical characteristics of COVID-19 in 104 people with SARS-CoV-2 infection on the Diamond Princess cruise ship: a retrospective analysis.
Tabata S; Imai K; Kawano S; Ikeda M; Kodama T; Miyoshi K; Obinata H; Mimura S; Kodera T; Kitagaki M; Sato M; Suzuki S; Ito T; Uwabe Y; Tamura K
Lancet Infect Dis; 2020 Sep; 20(9):1043-1050. PubMed ID: 32539988
[TBL] [Abstract][Full Text] [Related]
36. COVID-19: a conundrum to decipher.
Deshmukh V; Tripathi SC; Pandey A; Deshmukh V; Vykoukal J; Patil A; Sontakke B
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5830-5841. PubMed ID: 32495923
[TBL] [Abstract][Full Text] [Related]
37. Will SARS-COV-2 infection accelerate the incidence of Alzheimer's disease in Down syndrome population?
Barišić A; Vraneković J
Aging Clin Exp Res; 2022 Nov; 34(11):2919-2920. PubMed ID: 36266381
[No Abstract] [Full Text] [Related]
38. Minor Clinical Impact of COVID-19 Pandemic on Patients With Primary Immunodeficiency in Israel.
Marcus N; Frizinsky S; Hagin D; Ovadia A; Hanna S; Farkash M; Maoz-Segal R; Agmon-Levin N; Broides A; Nahum A; Rosenberg E; Kuperman AA; Dinur-Schejter Y; Berkun Y; Toker O; Goldberg S; Confino-Cohen R; Scheuerman O; Badarneh B; Epstein-Rigbi N; Etzioni A; Dalal I; Somech R
Front Immunol; 2020; 11():614086. PubMed ID: 33519822
[TBL] [Abstract][Full Text] [Related]
39. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.
Zhang JJ; Dong X; Cao YY; Yuan YD; Yang YB; Yan YQ; Akdis CA; Gao YD
Allergy; 2020 Jul; 75(7):1730-1741. PubMed ID: 32077115
[TBL] [Abstract][Full Text] [Related]
40. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
Stratton CW; Tang YW; Lu H
J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
